Loading...
UK Trademark — IPO
GAMHALTY
Application UK00916212425 · Registered
Quick Facts
| Application Number | UK00916212425 |
| Status | Registered |
| Owner | NovImmune SA |
| Filed | 2016-12-28 |
| Registered | 2017-05-01 |
| Renewal Due | 2026-12-28 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Is this trademark active?
Yes. GAMHALTY is currently a registered UK trademark, with renewal due on 2026-12-28. It is protected under UK intellectual property law and can be enforced against infringing uses.
Goods & Services
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Class 1 — Chemicals
Biochemicals, namely, polypeptides, superantigens, biomarkers and antibodies for medical and scientific research; cells, cell extracts and components of cells for medical and scientific research; diagnostic agents for medical and scientific research; diagnostic biomarker reagent for biomarker reagents for medical and scientific research; diagnostic test kits consisting primarily of biomarkers for medical and scientific research; biochemical test kits consisting of assays and reagents for medical and scientific research purposes.
Class 5 — Pharmaceuticals
Pharmaceutical and biological preparations; pharmaceutical and biological preparations based on polypeptides, superantigens, biomarkers and antibodies; immunotherapies, pharmaceutical and biological preparations for use in the diagnosis, prevention, management and treatment of immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; therapeutic and diagnostic agents, preparations and substances for use in therapies for immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; biochemicals, polypeptides, antibodies, biomarkers and superantigens for use in diagnoses and therapies for immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; engineered cell therapies for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic test kits consisting primarily of biomarkers for medical purposes; biochemical test kits comprised of assays and reagents for medical, diagnostic and therapeutic purposes.
Timeline
- Filed: 2016-12-28
- Registered: 2017-05-01
- Renewal due: 2026-12-28
About This Trademark
'GAMHALTY' is a registered trademark on the UK IPO register, owned by NovImmune SA. The application (UK00916212425) was filed on 28 December 2016 and registered on 1 May 2017. The registration is set to expire on 28 December 2026.
This mark is recorded under multiple classes: Class 1 (chemicals for industrial, scientific & agricultural use); Class 5 (pharmaceuticals & medical preparations).
The trademark is represented by Cooley (UK) LLP.
Frequently Asked Questions
Who owns UK trademark UK00916212425 ('GAMHALTY')?
UK trademark UK00916212425 for the mark 'GAMHALTY' in Class 1, 5 is recorded on the UK IPO register as owned by NovImmune SA. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Is UK trademark UK00916212425 currently a registered trademark?
Yes — the UK IPO records UK trademark UK00916212425 for the mark 'GAMHALTY' as registered.
Which Nice classes is UK trademark UK00916212425 registered under?
UK trademark UK00916212425 for the mark 'GAMHALTY' is recorded in Class 1 (chemicals for industrial, scientific & agricultural use); Class 5 (pharmaceuticals & medical preparations). The filed specification reads: Class 1: Biochemicals, namely, polypeptides, superantigens, biomarkers and antibodies for medical and scientific research; cells, cell extracts and components of cells for medical and scientific research; diagnostic agents for medical and scientific research; diagnostic biomarker reagent for biomarker reagents for m…
When was UK trademark UK00916212425 filed?
UK trademark UK00916212425 for the mark 'GAMHALTY' was filed at the UK IPO on 28 December 2016 and registered on 1 May 2017.
When does UK trademark UK00916212425 need to be renewed?
UK trademark UK00916212425 for the mark 'GAMHALTY' is currently recorded as valid until 28 December 2026, at which point it will need to be renewed with the UK IPO to remain in force.
Who is the attorney of record for UK trademark UK00916212425?
Cooley (UK) LLP is listed as the attorney / representative of record for UK trademark UK00916212425 for the mark 'GAMHALTY' on the UK IPO register.
Attorney of Record
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Cross-Register Filings
Trademarks matching "GAMHALTY" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
US — United States (USPTO)
| Mark | Ref | Status | Filed |
|---|---|---|---|
| GAMHALTYSame applicant | 87283837 | 710 | 2016-12-29 |
Data Source
United Kingdom (Intellectual Property Office)
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
United States (USPTO)
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.